S
Stockadora
Back to Insider Trading View Full Company Profile

NUVL

HEALTHY

Nuvalent, Inc.

CIK: 0001861560

Strong Sell (90% confidence)

Last activity: 2 weeks ago

Financial Metrics

As of Dec 31, 2024 (10-K)

Net Income -$260.76M
Total Cash $335.39M

Insider Roster (8 total, 8 active)

Insider Buys Sells Net Value Holdings
Flynn James E
TEN_PERCENT_OWNER
 		0 2 -$70.87M
8,299,225 shares
$792.12M
Miller Deborah Ann
Chief Legal Officer
 		0 15 -$5.89M
59,634 shares
$6.57M
Balcom Alexandra
Chief Financial Officer
 		0 17 -$3.57M
81,958 shares
$7.98M
Porter James Richard
President and CEO
 		0 7 -$2.67M
279,304 shares
$27.18M
Noci Darlene
Chief Development Officer
 		0 15 -$2.12M
59,999 shares
$6.11M
Shair Matthew
OTHER
 		0 8 -$820K
1,380,413 shares
$150.09M
Turner Christopher Durant
Chief Medical Officer
 		0 7 -$721K
55,355 shares
$5.39M
Pelish Henry E.
Chief Scientific Officer
 		0 7 -$502K
66,077 shares
$6.43M

Recent Transactions

SELL Noci Darlene (Chief Development Officer)

3,429 shares @ $101.80

$349K

Jan 29, 2026

Conviction: | View SEC Filing →
SELL Noci Darlene (Chief Development Officer)

1,819 shares @ $102.67

$187K

Jan 29, 2026

Conviction: | View SEC Filing →
SELL Noci Darlene (Chief Development Officer)

189 shares @ $100.95

$19K

Jan 29, 2026

Conviction: | View SEC Filing →
SELL Noci Darlene (Chief Development Officer)

63 shares @ $103.39

$7K

Jan 29, 2026

Conviction: | View SEC Filing →
SELL Miller Deborah Ann (Chief Legal Officer)

14,300 shares @ $110.16

$1.58M

Jan 22, 2026

Conviction: | View SEC Filing →
SELL Miller Deborah Ann (Chief Legal Officer)

700 shares @ $109.84

$77K

Jan 21, 2026

Conviction: | View SEC Filing →
SELL Porter James Richard (President and CEO)

4,905 shares @ $97.33

$477K

Jan 6, 2026

Conviction: | View SEC Filing →
SELL Porter James Richard (President and CEO)

3,963 shares @ $96.75

$383K

Jan 6, 2026

Conviction: | View SEC Filing →
SELL Noci Darlene (Chief Development Officer)

1,635 shares @ $97.33

$159K

Jan 6, 2026

Conviction: | View SEC Filing →
SELL Balcom Alexandra (Chief Financial Officer)

1,635 shares @ $97.33

$159K

Jan 6, 2026

Conviction: | View SEC Filing →
SELL Turner Christopher Durant (Chief Medical Officer)

1,635 shares @ $97.33

$159K

Jan 6, 2026

Conviction: | View SEC Filing →
SELL Pelish Henry E. (Chief Scientific Officer)

1,369 shares @ $97.33

$133K

Jan 6, 2026

Conviction: | View SEC Filing →
SELL Miller Deborah Ann (Chief Legal Officer)

1,331 shares @ $97.33

$130K

Jan 6, 2026

Conviction: | View SEC Filing →
SELL Turner Christopher Durant (Chief Medical Officer)

1,321 shares @ $96.75

$128K

Jan 6, 2026

Conviction: | View SEC Filing →
SELL Balcom Alexandra (Chief Financial Officer)

1,321 shares @ $96.75

$128K

Jan 6, 2026

Conviction: | View SEC Filing →
SELL Noci Darlene (Chief Development Officer)

1,321 shares @ $96.75

$128K

Jan 6, 2026

Conviction: | View SEC Filing →
SELL Pelish Henry E. (Chief Scientific Officer)

1,106 shares @ $96.75

$107K

Jan 6, 2026

Conviction: | View SEC Filing →
SELL Miller Deborah Ann (Chief Legal Officer)

1,075 shares @ $96.75

$104K

Jan 6, 2026

Conviction: | View SEC Filing →
SELL Porter James Richard (President and CEO)

675 shares @ $98.40

$66K

Jan 6, 2026

Conviction: | View SEC Filing →
SELL Turner Christopher Durant (Chief Medical Officer)

225 shares @ $98.40

$22K

Jan 6, 2026

Conviction: | View SEC Filing →
SELL Noci Darlene (Chief Development Officer)

225 shares @ $98.40

$22K

Jan 6, 2026

Conviction: | View SEC Filing →
SELL Balcom Alexandra (Chief Financial Officer)

225 shares @ $98.40

$22K

Jan 6, 2026

Conviction: | View SEC Filing →
SELL Pelish Henry E. (Chief Scientific Officer)

189 shares @ $98.40

$19K

Jan 6, 2026

Conviction: | View SEC Filing →
SELL Miller Deborah Ann (Chief Legal Officer)

183 shares @ $98.40

$18K

Jan 6, 2026

Conviction: | View SEC Filing →
SELL Porter James Richard (President and CEO)

8,147 shares @ $97.96

$798K

Jan 5, 2026

Conviction: | View SEC Filing →
SELL Porter James Richard (President and CEO)

4,727 shares @ $96.85

$458K

Jan 5, 2026

Conviction: | View SEC Filing →
SELL Porter James Richard (President and CEO)

3,679 shares @ $96.06

$353K

Jan 5, 2026

Conviction: | View SEC Filing →
SELL Miller Deborah Ann (Chief Legal Officer)

1,987 shares @ $97.96

$195K

Jan 5, 2026

Conviction: | View SEC Filing →
SELL Noci Darlene (Chief Development Officer)

1,929 shares @ $97.96

$189K

Jan 5, 2026

Conviction: | View SEC Filing →
SELL Turner Christopher Durant (Chief Medical Officer)

1,929 shares @ $97.96

$189K

Jan 5, 2026

Conviction: | View SEC Filing →
SELL Balcom Alexandra (Chief Financial Officer)

1,929 shares @ $97.96

$189K

Jan 5, 2026

Conviction: | View SEC Filing →
SELL Porter James Richard (President and CEO)

1,337 shares @ $98.52

$132K

Jan 5, 2026

Conviction: | View SEC Filing →
SELL Miller Deborah Ann (Chief Legal Officer)

1,153 shares @ $96.85

$112K

Jan 5, 2026

Conviction: | View SEC Filing →
SELL Pelish Henry E. (Chief Scientific Officer)

1,137 shares @ $97.96

$111K

Jan 5, 2026

Conviction: | View SEC Filing →
SELL Balcom Alexandra (Chief Financial Officer)

1,119 shares @ $96.85

$108K

Jan 5, 2026

Conviction: | View SEC Filing →
SELL Noci Darlene (Chief Development Officer)

1,119 shares @ $96.85

$108K

Jan 5, 2026

Conviction: | View SEC Filing →
SELL Turner Christopher Durant (Chief Medical Officer)

1,119 shares @ $96.85

$108K

Jan 5, 2026

Conviction: | View SEC Filing →
SELL Miller Deborah Ann (Chief Legal Officer)

897 shares @ $96.06

$86K

Jan 5, 2026

Conviction: | View SEC Filing →
SELL Noci Darlene (Chief Development Officer)

871 shares @ $96.06

$84K

Jan 5, 2026

Conviction: | View SEC Filing →
SELL Turner Christopher Durant (Chief Medical Officer)

871 shares @ $96.06

$84K

Jan 5, 2026

Conviction: | View SEC Filing →
SELL Balcom Alexandra (Chief Financial Officer)

871 shares @ $96.06

$84K

Jan 5, 2026

Conviction: | View SEC Filing →
SELL Pelish Henry E. (Chief Scientific Officer)

660 shares @ $96.85

$64K

Jan 5, 2026

Conviction: | View SEC Filing →
SELL Pelish Henry E. (Chief Scientific Officer)

513 shares @ $96.06

$49K

Jan 5, 2026

Conviction: | View SEC Filing →
SELL Miller Deborah Ann (Chief Legal Officer)

326 shares @ $98.52

$32K

Jan 5, 2026

Conviction: | View SEC Filing →
SELL Noci Darlene (Chief Development Officer)

317 shares @ $98.52

$31K

Jan 5, 2026

Conviction: | View SEC Filing →
SELL Turner Christopher Durant (Chief Medical Officer)

317 shares @ $98.52

$31K

Jan 5, 2026

Conviction: | View SEC Filing →
SELL Balcom Alexandra (Chief Financial Officer)

317 shares @ $98.52

$31K

Jan 5, 2026

Conviction: | View SEC Filing →
SELL Pelish Henry E. (Chief Scientific Officer)

186 shares @ $98.52

$18K

Jan 5, 2026

Conviction: | View SEC Filing →
SELL Miller Deborah Ann (Chief Legal Officer)

5,455 shares @ $100.77

$550K

Jan 2, 2026

Conviction: | View SEC Filing →
SELL Miller Deborah Ann (Chief Legal Officer)

4,005 shares @ $100.03

$401K

Jan 2, 2026

Conviction: | View SEC Filing →
SELL Miller Deborah Ann (Chief Legal Officer)

540 shares @ $101.47

$55K

Jan 2, 2026

Conviction: | View SEC Filing →
SELL Noci Darlene (Chief Development Officer)

3,358 shares @ $99.82

$335K

Dec 30, 2025

Conviction: | View SEC Filing →
SELL Noci Darlene (Chief Development Officer)

642 shares @ $101.22

$65K

Dec 30, 2025

Conviction: | View SEC Filing →
SELL Balcom Alexandra (Chief Financial Officer)

6,984 shares @ $110.31

$770K

Dec 8, 2025

Conviction: | View SEC Filing →
SELL Balcom Alexandra (Chief Financial Officer)

100 shares @ $111.32

$11K

Dec 8, 2025

Conviction: | View SEC Filing →
SELL Noci Darlene (Chief Development Officer)

3,355 shares @ $108.72

$365K

Nov 28, 2025

Conviction: | View SEC Filing →
SELL Noci Darlene (Chief Development Officer)

645 shares @ $107.85

$70K

Nov 28, 2025

Conviction: | View SEC Filing →
SELL Flynn James E (TEN_PERCENT_OWNER)

371,287 shares @ $95.44

$35.44M

Nov 24, 2025

Conviction: | View SEC Filing →
SELL Flynn James E (TEN_PERCENT_OWNER)

371,287 shares @ $95.44

$35.44M

Nov 24, 2025

Conviction: | View SEC Filing →
SELL Shair Matthew (OTHER)

2,262 shares @ $108.73

$246K

Nov 24, 2025

Conviction: | View SEC Filing →
SELL Shair Matthew (OTHER)

2,026 shares @ $109.77

$222K

Nov 24, 2025

Conviction: | View SEC Filing →
SELL Shair Matthew (OTHER)

1,193 shares @ $110.42

$132K

Nov 24, 2025

Conviction: | View SEC Filing →
SELL Shair Matthew (OTHER)

638 shares @ $108.73

$69K

Nov 24, 2025

Conviction: | View SEC Filing →
SELL Shair Matthew (OTHER)

572 shares @ $109.77

$63K

Nov 24, 2025

Conviction: | View SEC Filing →
SELL Shair Matthew (OTHER)

369 shares @ $107.70

$40K

Nov 24, 2025

Conviction: | View SEC Filing →
SELL Shair Matthew (OTHER)

336 shares @ $110.42

$37K

Nov 24, 2025

Conviction: | View SEC Filing →
SELL Shair Matthew (OTHER)

104 shares @ $107.70

$11K

Nov 24, 2025

Conviction: | View SEC Filing →
SELL Balcom Alexandra (Chief Financial Officer)

509 shares @ $104.54

$53K

Nov 18, 2025

Conviction: | View SEC Filing →
SELL Balcom Alexandra (Chief Financial Officer)

220 shares @ $103.61

$23K

Nov 18, 2025

Conviction: | View SEC Filing →
SELL Miller Deborah Ann (Chief Legal Officer)

15,075 shares @ $105.16

$1.59M

Nov 17, 2025

Conviction: | View SEC Filing →
SELL Miller Deborah Ann (Chief Legal Officer)

8,517 shares @ $105.98

$903K

Nov 17, 2025

Conviction: | View SEC Filing →
SELL Balcom Alexandra (Chief Financial Officer)

5,055 shares @ $103.27

$522K

Nov 17, 2025

Conviction: | View SEC Filing →
SELL Balcom Alexandra (Chief Financial Officer)

4,496 shares @ $100.58

$452K

Nov 17, 2025

Conviction: | View SEC Filing →
SELL Balcom Alexandra (Chief Financial Officer)

3,609 shares @ $93.80

$339K

Nov 17, 2025

Conviction: | View SEC Filing →
SELL Balcom Alexandra (Chief Financial Officer)

3,194 shares @ $102.13

$326K

Nov 17, 2025

Conviction: | View SEC Filing →
SELL Balcom Alexandra (Chief Financial Officer)

3,266 shares @ $95.12

$311K

Nov 17, 2025

Conviction: | View SEC Filing →
SELL Miller Deborah Ann (Chief Legal Officer)

608 shares @ $107.04

$65K

Nov 17, 2025

Conviction: | View SEC Filing →
SELL Balcom Alexandra (Chief Financial Officer)

380 shares @ $103.68

$39K

Nov 17, 2025

Conviction: | View SEC Filing →

⚠️ Important Disclaimer

• This is AI-generated analysis for educational purposes only, not financial advice.

• Insider trading data is derived from SEC Form 4 filings and may contain errors.

• Always conduct your own research and consult qualified financial advisors before making investment decisions.